Year: 2026

VANCOUVER, British Columbia, April 02, 2026 (GLOBE NEWSWIRE) — Domestic Metals Corp. (the “Company” or “Domestic Metals”) – (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E0) is pleased to report that a recently completed induced polarization (“IP”) geophysical survey at its Smart Creek copper-gold-silver Project in Montana (Figure 1) identified chargeability features that support the project’s target potential. The newly enhanced targets include extensive porphyry copper style zones in addition to carbonate replacement (“CRD”)/skarn copper-gold silver mineralization. The IP chargeability features of interest are widespread, coincident with previously established alteration footprints and high-grade sampling carried out by the Company (see news release dated January 8, 2026). The IP targets are interpreted to represent previously untested...

Fast Track Designation highlights potential of CTIM-76 to address unmet need for patients with PROC CTIM-76 Phase 1a trial ongoing, with interim data expected in June 2026 PHILADELPHIA, April 02, 2026 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track Designation to CTIM-76, a CLDN6 x CD3 T cell engaging bispecific antibody, for the treatment of platinum-resistant ovarian cancer (“PROC”) in patients that have received all standard of care therapies. Context is currently evaluating CTIM-76 in a Phase 1 clinical trial designed to evaluate the safety and efficacy of CTIM-76 in subjects with...

HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) — CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), today announces a new payer coverage agreement with Highmark, effective April 1, 2026, providing reimbursement for its CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) assay for patients with metastatic central nervous system cancers. Highmark joins a growing list of national and regional payers, including United Healthcare and Humana, that provide coverage for CNSide. The addition of Highmark expands CNSide’s total covered lives from approximately 67 million to 75 million, representing continued progress toward the Company’s 2026 objective of 150 million covered lives, while expanding patient access across the U.S. The agreement is expected to further accelerate...

Campaign to test extension of pegmatite system and evaluatepotential for niobium and rare earths Vancouver, British Columbia, April 02, 2026 (GLOBE NEWSWIRE) — Drills are turning for the first time at North American Niobium and Critical Minerals Corp.’s (CSE: NIOB) (FSE: KS82.F) (OTCQB: NIOMF) (North American Niobium or the Company) Seigneurie Project. “The team has wasted no time. We announced receipt of the key authorization last week, and the drill is already running this week. This first phase is designed to test the extension of the pegmatite system and evaluate its potential to host niobium and rare earth mineralization,” said Murray Nye, North American Niobium’s Chief Executive Officer. “The results will help guide the next stage of exploration at Seigneurie.” HighlightsDiamond drilling has commenced at the 100%-owned Seigneurie...

MALVERN, Pa., April 02, 2026 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced the issuance of U.S. Patent No. 12,582,632 B2, covering prevention and treatment of neurological injuries arising from brain infections through the administration of buntanetap or related compounds. The role of infectious agents in the development of AD has gained significant scientific attention in recent years. Research emerging from the brain microbiome studies has demonstrated that viral, bacterial, fungal, protozoan, or parasitic infections may lie at the heart of Alzheimer’s pathology. Established...

How Mine Production and Milling Capacity Expansion on TrackRedwing Mine Restart Program Advances with Dewatering MilestoneTulani Sikwila Named CEO and Leadership Team Expanded to Support Growth StrategyManagement to Host Business Update Conference Call on April 2nd at 8.30am NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) — Namib Minerals (“Namib” or “the Company”), (Nasdaq: NAMM), the African mining platform capitalizing on strategic resource opportunities, today announced its full year 2025 financial results and provided a business update highlighting its operational progress, leadership team enhancement and improving market conditions as the Company advances its strategy to build a multi-asset African mining platform. “Namib Minerals continues to make disciplined progress against our strategic roadmap to expand production,” said Tulani...

Kate Layton and Gaurav Rana to jointly lead Oportun on an interim basis as Board of Directors advances CEO search SAN MATEO, Calif., April 02, 2026 (GLOBE NEWSWIRE) — Oportun Financial Corporation (Nasdaq: OPRT) (“Oportun” or the “Company”), a mission-driven financial services company, today announced that Kate Layton and Gaurav Rana will assume interim leadership of the company through a joint Office of the CEO, effective April 4, 2026, following the previously announced departure of Raul Vazquez as Chief Executive Officer and a member of Oportun’s Board of Directors (the “Board”). Ms. Layton and Mr. Rana will continue in their current roles as Chief Legal Officer and Corporate Secretary and General Manager of Lending, respectively, as they assume their new responsibilities while the Board completes its search for a permanent CEO....

SAN DIEGO and SUZHOU, China, April 02, 2026 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene” or the “Company”) (Nasdaq: ADAG), a company committed to transforming the discovery and development of novel antibody-based therapies, today announced the pricing of its underwritten public offering of 18,666,000 American depositary shares, or ADSs, each representing 1.25 ordinary shares of the Company, par value US$0.0001 per share, at the offering price of US$3.75 per ADS, representing the 30-day volume-weighted average price (“VWAP”). The gross proceeds to Adagene from the offering are expected to be approximately US$70.0 million, before deducting underwriting discount and offering expenses. The offering is expected to close on April 6, 2026, subject to the satisfaction of customary closing conditions. Leerink Partners and LifeSci Capital are...

Secure Development Processes Advance CRA Readiness and Increase Customer Cybersecurity Assurance CHANDLER, Ariz., April 02, 2026 (GLOBE NEWSWIRE) — As connected systems spread across residential, industrial and commercial environments, the need for independently verified cybersecurity assurance is becoming a core requirement. To help address this demand, Microchip Technology (Nasdaq: MCHP) has been certified by UL Solutions to the IEC 62443‑4‑1 Maturity Level 2 (ML2) Industrial Automation and Control System standard, demonstrating that its new product development process meets globally recognized secure by design criteria. The certification provides audit-backed assurance that products are developed under a mature, repeatable and independently verified cybersecurity framework. The IEC 62443‑4‑1 standard defines the requirements...

RESTON, Va., April 02, 2026 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that President and CEO Seth Grae will present at three upcoming investor conferences in April 2026. Jefferies Virtual Nuclear Conference — Wednesday, April 8, 2026Seth Grae will deliver a presentation at 8:45 a.m. ET. The virtual event brings together companies across the nuclear energy and uranium sectors to discuss industry growth and strategic developments. Interested parties should contact their Jefferies representative to obtain access to the webcast. Gabelli Funds 12th Annual Waste & Environmental Services Symposium — Thursday, April 9, 2026 | New York, N.Y.Seth Grae will deliver a presentation at 2:00 p.m. ET. The symposium convenes institutional...